Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Hologic to Announce Financial Results for the First Quarter of Fiscal 2019 on Wednesday, January 30, 2019

Hologic,Inc.
Posted on: 07 Jan 19

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2019 on Wednesday, January 30, 2019, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

Interested participants may listen to the call by dialing 888-204-4368 (in the United States) or +1 323-794-2423 (for international callers) and referencing access code 4938132. Participants should dial in 5-10 minutes before the call begins. A replay will be available approximately two hours after the call ends through Friday, February 22, 2019. The replay numbers are 888-203-1112 (U.S.) or +1 719-457-0820 (international), access code 4938132, PIN 7304.

Hologic will provide a live webcast of the call on the Company’s website at www.investors.hologic.com. The call will be archived there for 30 days.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005183/en/

Business Wire
www.businesswire.com

Last updated on: 07/01/2019

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.